RQ Biotechnology

RQ Biotechnology Limited is dedicated to developing therapeutic and preventive treatments based on potent, broad-spectrum monoclonal antibodies, providing immediate and lasting immunity for populations at risk of severe illness or death due to existing or emerging viral infections. The management team comes from well-known pharmaceutical companies or research institutions such as Sanofi, Pfizer, Imperial College London, and the University of Oxford.